rs10090154: Understanding 8q24 Variants and Prostate Cancer Risk
The rs10090154 variant is a single nucleotide polymorphism located in the 8q24 region of the human genome. Research has identified this variant as being associated with an increased risk of developing prostate cancer, particularly in certain populations.
What each genotype means
Baseline prostate cancer risk
This genotype represents the non-risk version of the variant at the 8q24 region. Research indicates that individuals with this genotype do not carry the specific allele associated with increased prostate cancer risk in certain populations, such as northern Chinese men.
Frequency data for this specific genotype is not widely specified in current literature.
Increased prostate cancer risk
This genotype includes one copy of the risk-associated allele at the 8q24 locus. Studies have observed that this variant is associated with prostate cancer risk and clinical covariates, such as tumor stage, in specific cohorts. This finding is a statistical association and does not constitute a medical diagnosis; please discuss any concerns about prostate health or screening with your physician.
Frequency data for this specific genotype is not widely specified in current literature.
Elevated prostate cancer risk
This genotype includes two copies of the risk-associated allele at the 8q24 locus. Research has linked this variant to an increased risk of prostate cancer and differences in clinical presentation in certain populations. This is a statistical observation; please consult with your healthcare provider regarding appropriate prostate cancer screening based on your personal and family history.
Frequency data for this specific genotype is not widely specified in current literature.
What is rs10090154?
The rs10090154 variant is a specific genetic marker located on chromosome 8q24. In genetics, a single nucleotide polymorphism (SNP) like rs10090154 represents a variation at a single position in the DNA sequence. This particular region of chromosome 8 is well-known in the scientific community for harboring multiple variants that have been linked to prostate cancer susceptibility. Because rs10090154 is located in an intergenic region—meaning it sits in the DNA between protein-coding genes—it does not directly code for a protein itself. Instead, researchers believe that variants in this area may influence the regulation of nearby genes, potentially affecting how cells grow or respond to signals. It is important to note that having this variant does not mean an individual will develop cancer; rather, it is one of many factors that researchers study to understand the complex genetic architecture of prostate health.
Research and Evidence
The evidence linking rs10090154 to prostate cancer is considered moderate and has been observed across diverse populations. Several studies, including those focusing on Chinese cohorts, have reported significant associations between this variant and prostate cancer risk. For instance, some research has indicated that individuals carrying specific alleles at this locus show higher odds ratios for prostate cancer compared to those who do not. While these findings are statistically significant in the context of the studies conducted, the biological mechanisms remain a subject of ongoing investigation. Scientists are working to determine exactly how these non-coding variants on 8q24 contribute to disease development. Because prostate cancer is a multifactorial condition influenced by both genetics and environmental factors, rs10090154 is viewed as a piece of a much larger puzzle rather than a definitive diagnostic tool.
Population Frequency and Context
The frequency of the rs10090154 variant can vary significantly across different ancestral groups. While large-scale genomic databases often track the prevalence of common SNPs, specific frequency data for rs10090154 is not universally standardized across all global populations. Research has highlighted its relevance in both European and Asian cohorts, suggesting that the variant is not limited to a single ethnic group. However, the impact of genetic variants can be modified by ancestry, lifestyle, and environmental exposures. Because the prevalence of the risk allele differs by population, the absolute risk associated with the variant may also shift depending on an individual's genetic background. Researchers continue to conduct multi-ancestry studies to better understand how these risk loci function across the global population and to improve the accuracy of genetic risk prediction models.
What This Information Means for You
It is essential to understand that genetic variants like rs10090154 are used primarily for research and population-level risk assessment, not for individual medical diagnosis. If you are concerned about your prostate health or have a family history of prostate cancer, the most important step is to consult with a healthcare professional or a genetic counselor. They can provide personalized guidance based on your clinical history, age, and other established risk factors. You cannot change your genetic code, but understanding your risk profile can help you and your doctor make informed decisions about screening schedules and lifestyle choices. Avoid making health decisions based solely on raw genetic data from direct-to-consumer tests, as these results lack the clinical context required for medical decision-making. Always prioritize evidence-based screenings recommended by medical organizations.
How common is this variant?
The frequency of the rs10090154 variant varies by ancestry, with studies confirming its presence and association with prostate cancer risk in both European and Chinese populations.
Frequently asked questions
Does having the rs10090154 variant mean I will get prostate cancer?
No. Genetic variants like rs10090154 are associated with a statistical increase in risk, but they do not cause cancer on their own. Many people with this variant never develop prostate cancer, and many without it do.
Where can I get tested for rs10090154?
This variant is often included in large-scale genetic research panels or direct-to-consumer ancestry and health tests. However, clinical testing for this specific SNP is not a standard part of routine medical care.
Is rs10090154 the only gene linked to prostate cancer?
No. Prostate cancer is highly polygenic, meaning it is influenced by hundreds of different genetic variants across the genome. rs10090154 is just one of many loci identified by researchers.
Should I change my diet if I have this variant?
There is no specific diet recommended based on the rs10090154 variant. You should focus on general healthy lifestyle habits and discuss any specific health concerns with your primary care physician or a urologist.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10090154?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
Influences the efficiency of processing plant-based Omega-3 into EPA/DHA.
One of the strongest common genetic risk factors for breast cancer.
Causes the A- variant of G6PD deficiency, common in African populations.
Causes G6PD deficiency and favism risk in Mediterranean populations.
This variant in the CSMD1 gene is associated with clinical outcomes in multiple myeloma patients, specifically linked to early relapse and partial response groups.
This variant in the DCC netrin 1 receptor gene has been identified as a potential prognostic biomarker for clinical outcomes in patients with multiple myeloma.